Ying Ju

2.3k total citations
70 papers, 1.7k citations indexed

About

Ying Ju is a scholar working on Molecular Biology, Immunology and Cancer Research. According to data from OpenAlex, Ying Ju has authored 70 papers receiving a total of 1.7k indexed citations (citations by other indexed papers that have themselves been cited), including 29 papers in Molecular Biology, 23 papers in Immunology and 17 papers in Cancer Research. Recurrent topics in Ying Ju's work include Immune Cell Function and Interaction (8 papers), Galectins and Cancer Biology (8 papers) and MicroRNA in disease regulation (7 papers). Ying Ju is often cited by papers focused on Immune Cell Function and Interaction (8 papers), Galectins and Cancer Biology (8 papers) and MicroRNA in disease regulation (7 papers). Ying Ju collaborates with scholars based in China, United States and Czechia. Ying Ju's co-authors include Songdong Meng, Lizhao Chen, Chunhong Ma, Changfei Li, Yanzhong Wang, Hongxia Fan, Bingchang Zhang, Bao Zhao, Tsuyoshi Konuma and Lei Zeng and has published in prestigious journals such as SHILAP Revista de lepidopterología, The Journal of Immunology and Journal of Virology.

In The Last Decade

Ying Ju

66 papers receiving 1.7k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Ying Ju China 25 786 579 408 382 319 70 1.7k
Yasuyuki Watanabe Japan 15 580 0.7× 697 1.2× 281 0.7× 180 0.5× 254 0.8× 47 1.6k
Xuan Huang China 25 505 0.6× 466 0.8× 221 0.5× 215 0.6× 335 1.1× 113 1.7k
Sören T. Eichhorst Germany 17 596 0.8× 780 1.3× 137 0.3× 483 1.3× 310 1.0× 19 1.7k
Feng Shi China 21 750 1.0× 619 1.1× 274 0.7× 650 1.7× 404 1.3× 76 2.3k
Roba M. Talaat Egypt 20 402 0.5× 467 0.8× 147 0.4× 197 0.5× 224 0.7× 79 1.5k
Bei Cai China 24 644 0.8× 338 0.6× 145 0.4× 199 0.5× 365 1.1× 89 1.7k
Mazdak Ganjalıkhani-Hakemi Iran 23 665 0.8× 731 1.3× 305 0.7× 279 0.7× 124 0.4× 106 1.8k
HyeonJoo Cheon United States 17 722 0.9× 1.0k 1.8× 273 0.7× 880 2.3× 211 0.7× 20 2.0k
Cong Xu China 23 648 0.8× 339 0.6× 234 0.6× 223 0.6× 438 1.4× 126 1.7k

Countries citing papers authored by Ying Ju

Since Specialization
Citations

This map shows the geographic impact of Ying Ju's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ying Ju with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ying Ju more than expected).

Fields of papers citing papers by Ying Ju

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ying Ju. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ying Ju. The network helps show where Ying Ju may publish in the future.

Co-authorship network of co-authors of Ying Ju

This figure shows the co-authorship network connecting the top 25 collaborators of Ying Ju. A scholar is included among the top collaborators of Ying Ju based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ying Ju. Ying Ju is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Li, Haoran, Kang Chen, Lulin Cheng, et al.. (2025). FAM111B enhances glycolysis and promotes metastasis of prostate cancer by upregulating LDHA. Neoplasia. 69. 101227–101227.
2.
Chen, Jinyu, Chun‐Yu Liu, Haoran Li, et al.. (2025). TTK promotes mitophagy by regulating ULK1 phosphorylation and pre-mRNA splicing to inhibit mitochondrial apoptosis in bladder cancer. Cell Death and Differentiation. 32(9). 1691–1706.
3.
Liu, Xuzhou, Ying Ju, Chao Wang, et al.. (2025). Green tea fermented by Ganoderma lucidum presented anti-obesity properties via enhanced thermogenesis in vitro and on C57BL/6J mice. Food Research International. 207. 116092–116092. 2 indexed citations
4.
Liu, Xuzhou, Yanke Shi, Xiaoguo Wang, et al.. (2023). Ganoderma lingzhi culture enhance growth performance via improvement of antioxidant activity and gut probiotic proliferation in Sanhuang broilers. Frontiers in Veterinary Science. 10. 1143649–1143649. 4 indexed citations
5.
Ju, Ying, Changming Wang, Juanjuan Yu, et al.. (2023). Higenamine inhibits acute and chronic inflammatory pain through modulation of TRPV4 channels. European Journal of Pharmacology. 964. 176295–176295. 1 indexed citations
6.
Qian, Liyuan, Zihao Wang, Xin Li, et al.. (2023). Cellular gp96 upregulates AFP expression by blocking NR5A2 SUMOylation and ubiquitination in hepatocellular carcinoma. Journal of Molecular Cell Biology. 15(5). 4 indexed citations
7.
Shen, Liang, et al.. (2023). Treatments for cesarean scar pregnancy: 11-year experience at a medical center. The Journal of Maternal-Fetal & Neonatal Medicine. 36(1). 2162818–2162818. 9 indexed citations
8.
Qin, Lijuan, Fang Cheng, Jiamin Cheng, et al.. (2023). GPC3 and PEG10 peptides associated with placental gp96 elicit specific T cell immunity against hepatocellular carcinoma. Cancer Immunology Immunotherapy. 72(12). 4337–4354. 2 indexed citations
10.
Ye, Fan, Ying Ju, Jiao Chen, et al.. (2021). Cimifugin relieves pruritus in psoriasis by inhibiting TRPV4. Cell Calcium. 97. 102429–102429. 29 indexed citations
11.
Li, Jie, et al.. (2018). The regulatory role of Annexin 3 in a nude mouse bearing a subcutaneous xenograft of MDA-MB-231 human breast carcinoma. Pathology - Research and Practice. 214(10). 1719–1725. 11 indexed citations
12.
Zhang, Qiang, Lei Zeng, Chengcheng Zhao, et al.. (2016). Structural Insights into Histone Crotonyl-Lysine Recognition by the AF9 YEATS Domain. Structure. 24(9). 1606–1612. 75 indexed citations
13.
Zhang, Qiang, Lei Zeng, Chen Shen, et al.. (2016). Structural Mechanism of Transcriptional Regulator NSD3 Recognition by the ET Domain of BRD4. Structure. 24(7). 1201–1208. 54 indexed citations
14.
Feng, Mei, Juan Li, Jun Wang, et al.. (2014). High glucose increases LPS-induced DC apoptosis through modulation of ERK1/2, AKT and Bax/Bcl-2. BMC Gastroenterology. 14(1). 98–98. 24 indexed citations
15.
Yu, Xinshuang, Juan Du, Chunjuan Zhai, et al.. (2014). Clinical significance of serum soluble death receptor 5 concentration in locally advanced non-small cell lung cancer patients. Oncology Letters. 8(3). 1333–1339. 1 indexed citations
16.
Shen, Yajuan, Qian Wang, Bin Cui, et al.. (2014). Peripheral Foxp3+ regulatory T cells and natural killer group 2, member D expression levels in natural killer cells of patients with colorectal cancer. Molecular Medicine Reports. 10(2). 977–982. 2 indexed citations
17.
Zhao, Bao, Yanzhong Wang, Bo Wu, et al.. (2013). Placenta-derived gp96 as a multivalent prophylactic cancer vaccine. Scientific Reports. 3(1). 1947–1947. 21 indexed citations
18.
Qiu, Lipeng, Hongxia Fan, Wensong Jin, et al.. (2010). miR-122-induced down-regulation of HO-1 negatively affects miR-122-mediated suppression of HBV. Biochemical and Biophysical Research Communications. 398(4). 771–777. 127 indexed citations
19.
Chen, Lan, Huan Guo, Jing Yuan, et al.. (2010). Polymorphisms ofGSTT1andGSTM1and increased micronucleus frequencies in peripheral blood lymphocytes in residents at an e-waste dismantling site in China. Journal of Environmental Science and Health Part A. 45(4). 490–497. 18 indexed citations
20.
Liu, Hua, Fang Luan, Ying Ju, et al.. (2007). In vitro transfection of the hepatitis B virus PreS2 gene into the human hepatocarcinoma cell line HepG2 induces upregulation of human telomerase reverse transcriptase. Biochemical and Biophysical Research Communications. 355(2). 379–384. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026